Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Agfa-Gevaert    AGFB   BE0003755692

AGFA-GEVAERT (AGFB)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

AGFA-GEVAERT : Annual General Meeting of Agfa-Gevaert

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/24/2012 | 02:31pm CEST
  • Press Release
  • Mortsel (Belgium)
  • April 24, 2012 02:00

At Agfa-Gevaert's Annual General Meeting today, all the voting points on the agenda were approved. These included the approval of the 2011 financial statements, the allocation of the result as well as the discharge of directors and auditors.

The shareholders also approved the reappointment of De Wilde J Management BVBA, with permanent representative Julien De Wilde, and Christian Leysen as members of the Board of Directors. Finally, the General Meeting resolved, in accordance with article 556 of the Companies Code, to approve the change-of-control provisions, as stipulated in the Facility Agreement dated May 31, 2011 with Fortis Bank SA/NV, ING Belgium SA/NV and KBC Bank NV on the one hand and Agfa HealthCare NV, Agfa Graphics NV and Agfa-Gevaert NV on the other hand.

At the consequent Extraordinary General Meeting today - all the voting points on the agenda, all of them regarding changes in the articles of association - were approved, except for voting point n°3 regarding the spread in time of the variable remuneration.


Viviane Dictus
Director Corporate Communication
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 7124
fax+32 (0) 3 444 4485
[email protected]
Johan Jacobs
Corporate Press Relations Manager
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 8015
fax+32 (0) 3 444 4485
[email protected]
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AGFA-GEVAERT
05/23AGFA GEVAERT : Graphics implements substantial price increase program for its pr..
PU
05/23AGFA-GEVAERT : Agfa Graphics implements substantial price increase program for i..
AQ
05/08AGFA GEVAERT : Jaarlijkse Algemene Aandeelhoudersvergadering van Agfa-Gevaert NV
PU
05/08AGFA GEVAERT : publishes its first quarter 2018 results – regulated inform..
PU
05/08AGFA-GEVAERT PUBLISHES ITS FIRST QUA : 45 a.m. CET
GL
05/08AGFA-GEVAERT : Proxy Statments
CO
05/08AGFA-GEVAERT : 1st quarter results
CO
05/05AGFA GEVAERT : Siegwerk Adds Agfas UV Digital Packaging Inks to Inkjet Ink Portf..
AQ
04/18AGFA GEVAERT : Siegwerk and Agfa Graphics enter into strategic alliance
AQ
04/18AGFA GEVAERT : has reported a drop in both revenue and gross profit in its 2018 ..
AQ
More news
News from SeekingAlpha
05/08Agfa-Gavaert NV reports Q1 results 
03/09Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q4 2017 Results - Earnings C.. 
03/08Agfa-Gavaert NV ADR 2017 Q4 - Results - Earnings Call Slides 
03/07Agfa-Gavaert NV reports Q4 results 
2017Agfa-Gavaert NV reports Q3 results 
Financials (€)
Sales 2018 2 360 M
EBIT 2018 -
Net income 2018 63,0 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 6,36
P/E ratio 2019 7,08
Capi. / Sales 2018 0,23x
Capi. / Sales 2019 0,23x
Capitalization 535 M
Chart AGFA-GEVAERT
Duration : Period :
Agfa-Gevaert Technical Analysis Chart | AGFB | BE0003755692 | 4-Traders
Technical analysis trends AGFA-GEVAERT
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 4,70 €
Spread / Average Target 51%
EPS Revisions
Managers
NameTitle
Christian Reinaudo President, Chief Executive Officer & Director
Julien de Wilde Chairman
Dirk De Man Chief Financial Officer
Jozef Cornu Non-Executive Director
Willy W. Duron Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
AGFA-GEVAERT-19.84%624
THERMO FISHER SCIENTIFIC12.52%85 956
DANAHER CORPORATION10.15%71 345
INTUITIVE SURGICAL25.44%51 726
BOSTON SCIENTIFIC CORPORATION23.64%41 822
ROYAL PHILIPS13.78%39 823